ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,617.87
0.20%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. SAB Biotherapeutics Inc (SABS) Share Price

SABS SAB Biotherapeutics Inc

2.55
-0.09 (-3.41%)
01 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 SAB Biotherapeutics Inc NASDAQ:SABS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.09 -3.41 2.55 2.00 2.83 2.77 2.4701 2.63 4,222 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 2.24M -42.19M -4.5735 -0.56 23.53M
 Type  Size  Price  Time  Units 
 9 23 2.64 20:03:44 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SABS News
20/05/202422:45GLOBESAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
06/05/202412:15GLOBESAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
16/04/202412:15GLOBESAB Biotherapeutics Provides SAB-142 Trial Update
08/04/202412:15GLOBESAB Biotherapeutics to Present at INNODIA Annual Meeting
04/04/202412:15GLOBESAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference
29/03/202411:15GLOBESAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
25/03/202414:15GLOBESAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment
Period
Draw mode
Data Downloads for SABS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest SAB Biotherapeutics Inc Articles